Cargando…

Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based Chemotherapy

SIMPLE SUMMARY: High-risk soft tissue sarcomas (HR-STS) account for less than 1% of all malignancies in adults. Despite optimal local treatment, almost half of patients will die within five years of their diagnosis. Chemoresistance is a major responsible mechanism for treatment failure in advanced t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berclaz, Luc M., Altendorf-Hofmann, Annelore, Dürr, Hans Roland, Klein, Alexander, Angele, Martin K., Albertsmeier, Markus, Schmidt-Hegemann, Nina-Sophie, Di Gioia, Dorit, Knösel, Thomas, Lindner, Lars H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507907/ https://www.ncbi.nlm.nih.gov/pubmed/34638362 http://dx.doi.org/10.3390/cancers13194877

Ejemplares similares

TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)
por: Berclaz, Luc M., et al.
Publicado: (2023)

VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?
por: Albertsmeier, Markus, et al.
Publicado: (2022)

Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma
por: Albertsmeier, Markus, et al.
Publicado: (2020)

Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma
por: Bücklein, Veit, et al.
Publicado: (2020)

Sarcomas of the extremities and the pelvis: comparing local recurrence after incisional and after core-needle biopsy
por: Klein, Alexander, et al.
Publicado: (2022)

Implementing precision oncology for sarcoma patients: the CCC(LMU)molecular tumor board experience
por: Berclaz, Luc M., et al.
Publicado: (2023)

A novel immune-related gene signature predicting survival in sarcoma patients
por: Ren, Haoyu, et al.
Publicado: (2021)

Distinct Expression Patterns of VEGFR 1-3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Supporting Clinical Relevance, but not a Prognostic Factor
por: Bösch, Florian, et al.
Publicado: (2020)

Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms
por: Bösch, Florian, et al.
Publicado: (2022)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

The Effect of Resection Margin on Local Recurrence and Survival in High Grade Soft Tissue Sarcoma of the Extremities: How Far Is Far Enough?
por: Bilgeri, Annika, et al.
Publicado: (2020)

Impact of postoperative baseline MRI on diagnostic confidence and performance in detecting local recurrence of soft-tissue sarcoma of the limb
por: Goller, Sophia Samira, et al.
Publicado: (2023)

Neoadjuvant Treatment Options in Soft Tissue Sarcomas
por: Spałek, Mateusz Jacek, et al.
Publicado: (2020)

Amputation for Extremity Sarcoma: Indications and Outcomes
por: Kirilova, Maya, et al.
Publicado: (2021)

SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth
por: Ma, L, et al.
Publicado: (2014)

Neoadjuvant Chemoradiation Herapy for Soft Tissue Sarcomas of the Extremities
por: Aguiar, Samuel, et al.
Publicado: (2009)

Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas
por: Loong, Herbert H., et al.
Publicado: (2018)

Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ Breast Cancer: Real-World Evidence
por: de Pinho, Inês Soares, et al.
Publicado: (2023)

Hyperprogression of Liver Metastasis With Neoadjuvant Immunotherapy for Soft Tissue Sarcoma
por: Chan, Abigail S, et al.
Publicado: (2020)

Impact of age on morbidity and outcome of concurrent radiochemotherapy in high-risk FIGO stage I to IVA carcinoma of the uterine cervix following laparoscopic surgery
por: Laurentius, Thea, et al.
Publicado: (2010)

Impact of metabolic indices of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma
por: Bauschke, Astrid, et al.
Publicado: (2022)

Radiographic and Histologic Response to Neoadjuvant Radiotherapy in Patients With Soft Tissue Sarcoma
por: Canter, Robert J., et al.
Publicado: (2010)

Neoadjuvant radiotherapy for soft tissue sarcoma in China: a preliminary result
por: Huang, Zhen, et al.
Publicado: (2022)

Neoadjuvant Chemoradiation Compared With Neoadjuvant Radiation Alone in the Management of High-Grade Soft Tissue Extremity Sarcomas
por: Hazell, Sarah Z., et al.
Publicado: (2019)

Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosis
por: Bauschke, Astrid, et al.
Publicado: (2020)

Expression of SIRT1 and DBC1 Is Associated with Poor Prognosis of Soft Tissue Sarcomas
por: Kim, Jung Ryul, et al.
Publicado: (2013)

Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report
por: Patel, Ronak, et al.
Publicado: (2019)

Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma
por: Torrigiani, Filippo, et al.
Publicado: (2019)

Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy
por: Virgili Manrique, Anna C., et al.
Publicado: (2022)

The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma
por: Kobus, Marta, et al.
Publicado: (2022)

Chirurgische Therapie von Leber- und Pankreasmetastasen von Nierenzellkarzinomen
por: Bauschke, Astrid, et al.
Publicado: (2021)

FOXM1: A novel drug target in gastroenteropancreatic neuroendocrine tumors
por: Briest, Franziska, et al.
Publicado: (2015)

Relative Sensitivity of Core-Needle Biopsy and Incisional Biopsy in the Diagnosis of Musculoskeletal Sarcomas
por: Klein, Alexander, et al.
Publicado: (2021)

Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities
por: Curtis, Kelly K, et al.
Publicado: (2011)

Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy
por: Bedi, Meena, et al.
Publicado: (2013)

Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents
por: Callaghan, Cameron M., et al.
Publicado: (2020)

Intratumoral injection of holmium-166 microspheres as neoadjuvant therapy of soft tissue sarcomas in dogs
por: Morsink, Nino Chiron, et al.
Publicado: (2022)

Predictive Biomarkers of Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Soft Tissue Sarcomas
por: Szumera-Ciećkiewicz, Anna, et al.
Publicado: (2023)

Surgical treatment of liver metastases from non-colorectal non-neuroendocrine carcinomas
por: Bauschke, Astrid, et al.
Publicado: (2021)

Efficient lytic induction of kaposi's sarcoma-associated herpesvirus (KSHV) by the anthracyclines
por: Kang, Hyunju, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gpddp2j8jqfgjhde4if15vts94